Therapeutic treatments using the direct application of antimicrobial metal compositions
Details for Australian Patent Application No. 2002303438 (hide)
International Classifications
Event Publications
12 December 2002 Complete Application Filed
Priority application(s): 60/285,884 23.04.01 US; 09/840,637 23.04.01 US
17 April 2003 Application Open to Public Inspection
Published as AU-B-2002303438
25 October 2007 Application Accepted
Published as AU-B-2002303438
21 February 2008 Standard Patent Sealed
15 July 2010 Assignment Registered
Nucryst Pharmaceuticals Corp. The patent has been assigned to Smith & Nephew (Overseas) Limited
17 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002303439-CARDIAC NEUROMODULATION AND METHODS OF USING SAME
2002303437-ISOLATION OF NEURAL STEM CELLS USING GANGLIOSIDES AND OTHER SURFACE MARKERS
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser